These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 16304454

  • 1. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT.
    Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Management of hepatitis C virus coinfection in HIV-infected persons.
    O'Leary JG, Chung RT.
    AIDS Read; 2006 Jun; 16(6):313-6, 318-20. PubMed ID: 16795921
    [Abstract] [Full Text] [Related]

  • 5. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P, McNicholl IR.
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [Abstract] [Full Text] [Related]

  • 6. Treatment of hepatitis C virus/HIV coinfection.
    Chun S, Sherman KE.
    Clin Liver Dis; 2005 Aug; 9(3):525-33, ix. PubMed ID: 16023981
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of insulin resistance in HIV/hepatitis C virus-coinfected patients.
    Eslam M, López-Cortés LF, Romero-Gomez M.
    Curr Opin HIV AIDS; 2011 Nov; 6(6):553-8. PubMed ID: 21934619
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HIV and hepatitis C coinfection.
    Matthews GV, Dore GJ.
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [Abstract] [Full Text] [Related]

  • 13. Analysis of sequence configurations of the PKR-interacting HCV proteins from plasma and PBMC as predictors of response to interferon-alpha and ribavirin therapy in HIV-coinfected patients.
    Bolcic F, Bull L, Martinez L, Reynoso R, Salomon H, Arduino R, Barnett B, Quarleri J.
    Intervirology; 2008 Jul; 51(4):261-4. PubMed ID: 18824873
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.
    Schwarze-Zander C, Blackard JT, Zheng H, Addo MM, Lin W, Robbins GK, Sherman KE, Zdunek D, Hess G, Chung RT, AIDS Clinical Trial Group A5071 Study Team.
    J Infect Dis; 2006 Aug 15; 194(4):410-9. PubMed ID: 16845623
    [Abstract] [Full Text] [Related]

  • 17. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
    Bräu N.
    Semin Liver Dis; 2005 Feb 15; 25(1):33-51. PubMed ID: 15731996
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Coinfection with hepatitis C virus and HIV].
    Ruys TA, Reesink HW, Lange JM.
    Ned Tijdschr Geneeskd; 2003 Oct 18; 147(42):2056-60. PubMed ID: 14606352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.